The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 30th 2025
Biomarker testing transforms non-small cell lung cancer treatment, enhancing outcomes through targeted therapies and next-generation sequencing for better patient care.
FDA Approves Upadacitinib for Active Ankylosing Spondylitis
May 2nd 2022FDA approves 15 mg upadacitinib (Rinvoq; AbbVie) for the treatment of adult patients with active ankylosing spondylitis who previously showed an inadequate response or intolerance to 1 or more tumor necrosis factor inhibitors.
Read More
FDA Approves Osteseconazole for Recurrent Vulvovaginal Candidiasis
May 2nd 2022Osteseconazole (Vivjoa) is the first FDA-approved treatment for recurrent vulvovaginal candidiasis, also known as chronic yeast infection, in women with a history of the condition who are not of reproductive potential.
Read More
Nicole Palmer, senior manager of Volunteer Engagement at US Pharmacopeia (USP), and Michelle Then, PharmD, MBA, member of the USP Healthcare Safety and Quality Expert Committee, discuss the benefits of being a volunteer at USP and the opportunities for students and early career pharmacists.
Watch
Study: Antibiotic Prescription Rates for Black, Hispanic, Older Patients Are Alarmingly High
April 27th 2022Of these visits, approximately 11%, or 8 million, resulted in antibiotic prescriptions, foremost commonly for illnesses that are not caused by a bacterial infection, such as bronchitis, non-bacterial skin conditions, and viral respiratory-tract infections.
Read More